Fitzmaurice, C., et al.: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3(4), 524–548 (2017)
Article
PubMed
Google Scholar
Luengo-Fernandez, R., et al.: Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14(12), 1165–1174 (2013)
Article
PubMed
Google Scholar
Kuchenbaecker, K.B., et al.: Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23), 2402–2416 (2017)
CAS
Article
PubMed
Google Scholar
Graeser, M.K., et al.: Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35), 5887–5892 (2009)
Article
PubMed
Google Scholar
Walsh, T., et al.: Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A 108(44), 18032–18037 (2011)
CAS
Article
PubMed
PubMed Central
Google Scholar
Bowtell, D.D.: The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 10(11), 803–808 (2010)
CAS
Article
PubMed
Google Scholar
du Bois, A., et al.: Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer 115(6), 1234–1244 (2009)
Article
CAS
PubMed
Google Scholar
Antoniou, A., et al.: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5), 1117–1130 (2003)
CAS
Article
PubMed
PubMed Central
Google Scholar
Spurdle, A.B., et al.: Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res 16(6), 3419 (2014)
Article
PubMed
PubMed Central
Google Scholar
Kuchenbaecker, K.B., et al.: Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 16(6), 3416 (2014)
Article
PubMed
PubMed Central
Google Scholar
Hartmann, L.C., Lindor, N.M.: The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med 374(5), 454–468 (2016)
CAS
Article
PubMed
Google Scholar
Eleje, G.U., et al.: Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. Cochrane Database Syst Rev 8, CD012464 (2018)
PubMed
Google Scholar
Carbine, N.E., et al.: Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev 4, CD002748 (2018)
PubMed
Google Scholar
Rosenthal, A.N., et al.: Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom familial ovarian cancer screening study. J Clin Oncol 35(13), 1411–1420 (2017)
Article
PubMed
PubMed Central
Google Scholar
Buys, S.S., et al.: Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 305(22), 2295–2303 (2011)
CAS
Article
PubMed
Google Scholar
Skates, S.J., et al.: Early detection of ovarian cancer using the risk of ovarian cancer algorithm with frequent CA125 testing in women at increased familial risk—combined results from two screening trials. Clin Cancer Res 23(14), 3628–3637 (2017)
CAS
Article
PubMed
PubMed Central
Google Scholar
Fisher, B., et al.: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18), 1371–1388 (1998)
CAS
Article
PubMed
Google Scholar
Cuzick, J., et al.: Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet 383(9922), 1041–1048 (2014)
CAS
Article
PubMed
Google Scholar
Grann, V.R., et al.: Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat 125(3), 837–847 (2011)
CAS
Article
PubMed
Google Scholar
Muller, D., et al.: Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation. Eur J Health Econ 19(3), 341–353 (2018)
Article
PubMed
Google Scholar
Network, N.C.C.: Breast Cancer Risk Reduction. https://www.nccn.org/professionals/physician_gls/pdf/breast_risk.pdf (2021)
Bundesamt für Gesundheit (BAG)—Direktionsbereich Kranken- und Unfallversicherung; Referenzdokument "Überwachungsprotokoll" zu Artikel 12d Absatz 1 Buchstabe d der Krankenpflege-Leistungsverordnung (KLV) in Anlehnung an NICE Clinical Guideline 164 vom Juni 2013 (Stand 02/2015).
Matter-Walstra, K., et al.: A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing. J Thorac Oncol 11(11), 1846–1855 (2016)
Article
PubMed
Google Scholar
Bundesgericht.: Auszug aus dem Urteil der II. sozialrechtlichen Abteilung i.S. Publisana Krankenversicherung gegen F. (Beschwerde in öffentlich-rechtlichen Angelegenheiten) 9C_334/2010 vom 23. November 2010. http://relevancy.bger.ch/php/clir/http/index.php?highlight_docid=atf%3A%2F%2F136-V-395%3Ade&lang=de&type=show_document (2010)
Domchek, S.M., et al.: Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer. Cancer 119(7), 1344–1348 (2013)
CAS
Article
PubMed
Google Scholar
Yao, K., et al.: Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature. Ann Surg Oncol 22(2), 370–376 (2015)
Article
PubMed
Google Scholar
Parker, W.H., et al.: Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study. Obstet Gynecol 113(5), 1027–1037 (2009)
Article
PubMed
PubMed Central
Google Scholar
Jacoby, V.L., et al.: Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women’s Health Initiative Observational Study. Arch Intern Med 171(8), 760–768 (2011)
Article
PubMed
Google Scholar
Rocca, W.A., et al.: Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based cohort study. Mayo Clin Proc 91(11), 1577–1589 (2016)
Article
PubMed
Google Scholar
Klar, M., et al.: Prognostic factors in young ovarian cancer patients: an analysis of four prospective phase III intergroup trials of the AGO Study Group GINECO and NSGO. Eur J Cancer 66, 114–124 (2016)
CAS
Article
PubMed
Google Scholar
Landrum, L.M., et al.: Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a gynecologic oncology group study. Gynecol Oncol 130(1), 12–18 (2013)
Article
PubMed
PubMed Central
Google Scholar
Chirlaque, M.D., et al.: Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study. pp. S107–S113 (2017)
Swiss Federal Office of Statistics—mortality rates. http://www.bfs.admin.ch
Heemskerk-Gerritsen, B.A., et al.: Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction. J Natl Cancer Inst (2015). https://doi.org/10.1093/jnci/djv217
Article
PubMed
PubMed Central
Google Scholar
Kotsopoulos, J., et al.: Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2017). https://doi.org/10.1093/jnci/djx038
Article
PubMed
Google Scholar
Cuzick, J., et al.: Overview of the main outcomes in breast-cancer prevention trials. Lancet 361(9354), 296–300 (2003)
CAS
Article
PubMed
Google Scholar
Cuzick, J., et al.: Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet 381(9880), 1827–1834 (2013)
CAS
Article
PubMed
PubMed Central
Google Scholar
Foulkes, W.D., et al.: The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res 64(3), 830–835 (2004)
CAS
Article
PubMed
Google Scholar
Phillips, K.A., et al.: Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. J Clin Oncol 31(25), 3091–3099 (2013)
CAS
Article
PubMed
PubMed Central
Google Scholar
Powles, T.J., et al.: Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 99(4), 283–290 (2007)
CAS
Article
PubMed
Google Scholar
Torrance, G.W.: Measurement of health state utilities for economic appraisal. J Health Econ 5(1), 1–30 (1986)
CAS
Article
PubMed
Google Scholar
Sullivan, P.W., Ghushchyan, V.: Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making 26(4), 410–420 (2006)
Article
PubMed
PubMed Central
Google Scholar
Peasgood, T., Ward, S.E., Brazier, J.: Health-state utility values in breast cancer. Expert Rev Pharmacoecon Outcomes Res 10(5), 553–566 (2010)
Article
PubMed
Google Scholar
Ara, R., Wailoo, A.: Using health state utility values in models exploring the cost-effectiveness of health technologies. Value Health 15(6), 971–974 (2012)
Article
PubMed
Google Scholar
Thoma, A., et al.: Cost-utility analysis comparing free and pedicled TRAM flap for breast reconstruction. Microsurgery 23(4), 287–295 (2003)
Article
PubMed
Google Scholar
Havrilesky, L.J., et al.: Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers. Gynecol Oncol 145(3), 549–554 (2017)
Article
PubMed
Google Scholar
Zendejas, B., et al.: Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer. J Clin Oncol 29(22), 2993–3000 (2011)
Article
PubMed
PubMed Central
Google Scholar
Hatcher, M.B., Fallowfield, L., A’Hern, R.: The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 322(7278), 76 (2001)
CAS
Article
PubMed
PubMed Central
Google Scholar
Swiss DRG catalogue. https://www.swissdrg.org/de
Swiss Tarmed catalogue. https://www.tarmed-browser.ch/de/leistungen
Bundesamt für Gesundheit (BAG)—Swiss medication list (Spezialitätenliste; SL). http://www.xn--spezialittenliste-yqb.ch/
Vemer, P., et al.: AdViSHE: a validation-assessment tool of health-economic models for decision makers and model users. Pharmacoeconomics 34(4), 349–361 (2016)
CAS
Article
PubMed
Google Scholar
Anderson, K., et al.: Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med 144(6), 397–406 (2006)
Article
PubMed
Google Scholar
Grann, V.R., et al.: Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol 16(3), 979–985 (1998)
CAS
Article
PubMed
Google Scholar
Norum, J., et al.: Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis. Eur J Cancer 44(7), 963–971 (2008)
CAS
Article
PubMed
Google Scholar
Schrauder, M.G., et al.: Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer. Breast 32, 186–191 (2017)
Article
PubMed
Google Scholar
Papanicolas, I., Woskie, L.R., Jha, A.K.: Health care spending in the United States and other high-income countries. JAMA 319(10), 1024–1039 (2018)
Article
PubMed
Google Scholar
Wieser S., T.T., Riguzzi M., Fischer B., Telser H., Pletscher M., Eichler K., Trost M., Schwenkglenks M.: Die Kosten der nichtübertragbaren Krankheiten in der Schweiz—Schlussbericht (2014)
Metcalfe, K.A., et al.: International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122(9), 2017–2022 (2008)
CAS
Article
PubMed
PubMed Central
Google Scholar
Katapodi, M.C., et al.: Cancer predisposition cascade screening for hereditary breast/ovarian cancer and lynch syndromes in Switzerland: study protocol. JMIR Res Protoc 6(9), e184 (2017)
Article
PubMed
PubMed Central
Google Scholar
D’Alonzo, M., et al.: Satisfaction and impact on quality of life of clinical and instrumental surveillance and prophylactic surgery in BRCA-mutation carriers. Clin Breast Cancer 18(6), e1361–e1366 (2018)
Article
PubMed
Google Scholar
Madalinska, J.B., et al.: Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 23(28), 6890–6898 (2005)
Article
PubMed
Google Scholar
Metcalfe, K., et al.: Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. JAMA Oncol 1(3), 306–313 (2015)
Article
PubMed
Google Scholar
Moller, P., et al.: Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. Int J Cancer 101(6), 555–559 (2002)
CAS
Article
PubMed
Google Scholar
Huzarski, T., et al.: The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 156(2), 371–378 (2016)
CAS
Article
PubMed
Google Scholar
Kenkhuis, M.J., et al.: Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers. Maturitas 66(3), 310–314 (2010)
CAS
Article
PubMed
Google Scholar
Hall, E., et al.: Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol 152(1), 145–150 (2019)
CAS
Article
PubMed
Google Scholar
Tucker, P.E., et al.: Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy. Gynecol Oncol 140(1), 95–100 (2016)
Article
PubMed
Google Scholar
Finch, A., et al.: The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation. Psychooncology 22(1), 212–219 (2013)
Article
PubMed
Google Scholar
Metcalfe, K.A., et al.: Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation. Clin Genet 85(1), 21–30 (2014)
CAS
Article
PubMed
Google Scholar
Jagsi, R., et al.: Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg 152(3), 274–282 (2017)
Article
PubMed
PubMed Central
Google Scholar
Gahm, J., Wickman, M., Brandberg, Y.: Bilateral prophylactic mastectomy in women with inherited risk of breast cancer–prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast 19(6), 462–469 (2010)
Article
PubMed
Google Scholar
Brandberg, Y., et al.: Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26(24), 3943–3949 (2008)
Article
PubMed
Google Scholar
Heemskerk-Gerritsen, B.A., et al.: Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Ann Surg Oncol 14(12), 3335–3344 (2007)
Article
PubMed
PubMed Central
Google Scholar
Arver, B., et al.: Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: a national survey. Ann Surg 253(6), 1147–1154 (2011)
Article
PubMed
Google Scholar
Wilkins, E.G., et al.: Complications in postmastectomy breast reconstruction: one-year outcomes of the mastectomy reconstruction outcomes consortium (MROC) study. Ann Surg 267(1), 164–170 (2018)
Article
PubMed
Google Scholar
den Heijer, M., et al.: Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study. Eur J Cancer 48(9), 1263–1268 (2012)
Article
Google Scholar
McCarthy, C.M., et al.: Impact of bilateral prophylactic mastectomy and immediate reconstruction on health-related quality of life in women at high risk for breast carcinoma: results of the mastectomy reconstruction outcomes consortium study. Ann Surg Oncol 24(9), 2502–2508 (2017)
Article
PubMed
PubMed Central
Google Scholar
Mahat-Shamir, M., Possick, C.: The experience of women carriers of BRCA mutations following risk-reducing surgery: a cultural perspective. Health Care Women Int 38(4), 344–360 (2017)
Article
PubMed
Google Scholar
Bürki, N., et al.: Familiärer Bruskrebs—Diagnose, Beratung, Therapie und Langzeitbetreuung. Schulthess Verlag, Genf (2012)
Google Scholar
Anderson, R.: Systematic reviews of economic evaluations: utility or futility? Health Econ 19(3), 350–364 (2010)
Article
PubMed
Google Scholar
Cuzick, J., et al.: Long-term results of tamoxifen prophylaxis for breast cancer–96-month follow-up of the randomized IBIS-I trial. J Natl Cancer Inst 99(4), 272–282 (2007)
CAS
Article
PubMed
Google Scholar
Bainbridge, D., et al.: Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Lancet 380(9847), 1075–1081 (2012)
Article
PubMed
Google Scholar
Hennigs, A., et al.: Prognosis of breast cancer molecular subtypes in routine clinical care: a large prospective cohort study. BMC Cancer 16(1), 734 (2016)
Article
CAS
PubMed
PubMed Central
Google Scholar
Baretta, Z., et al.: Effect of BRCA germline mutations on breast cancer prognosis: a systematic review and meta-analysis. Medicine (Baltimore) 95(40), e4975 (2016)
CAS
Article
Google Scholar
Moore, K., et al.: Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med 379(26), 2495–2505 (2018)
CAS
Article
PubMed
Google Scholar
Chen, T., et al.: Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage. Eur J Cancer Prev 22(1), 59–67 (2013)
Article
PubMed
Google Scholar
Grann, V.R., et al.: Breast cancer-related preferences among women with and without BRCA mutations. Breast Cancer Res Treat 119(1), 177–184 (2010)
Article
PubMed
Google Scholar
Schrauder, M.G., et al.: Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy. Eur J Med Res 24(1), 32 (2019)
Article
CAS
PubMed
PubMed Central
Google Scholar
Krishnan, N.M., et al.: Is single-stage prosthetic reconstruction cost effective? a cost-utility analysis for the use of direct-to-implant breast reconstruction relative to expander-implant reconstruction in postmastectomy patients. Plast Reconstr Surg 138(3), 537–547 (2016)
CAS
Article
PubMed
Google Scholar
Gerber, B., et al.: Breast reconstruction following cancer treatment. Dtsch Arztebl Int 112(35–36), 593–600 (2015)
PubMed
PubMed Central
Google Scholar
Pusic, A.L., et al.: Patient-reported outcomes 1 year after immediate breast reconstruction: results of the mastectomy reconstruction outcomes consortium study. J Clin Oncol 35(22), 2499–2506 (2017)
Article
PubMed
PubMed Central
Google Scholar
Kotsopoulos, J., et al.: Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol 150(1), 85–91 (2018)
Article
PubMed
Google Scholar
Litiere, S., et al.: Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 13(4), 412–419 (2012)
Article
PubMed
Google Scholar
Domchek, S.M., et al.: Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9), 967–975 (2010)
CAS
Article
PubMed
PubMed Central
Google Scholar
Cumming, G., Fidler, F., Vaux, D.L.: Error bars in experimental biology. J Cell Biol 177(1), 7–11 (2007)
CAS
Article
PubMed
PubMed Central
Google Scholar
Rebbeck, T.R., et al.: Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6), 1055–1062 (2004)
Article
PubMed
Google Scholar
Boughey, J.C., et al.: Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol 17(10), 2702–2709 (2010)
Article
PubMed
PubMed Central
Google Scholar
Havrilesky, L.J., et al.: Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment. Gynecol Oncol 113(2), 216–220 (2009)
Article
PubMed
PubMed Central
Google Scholar
Ledermann, J.A., et al.: Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Oncol 17(11), 1579–1589 (2016)
CAS
Article
PubMed
Google Scholar